Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Ebneter

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Ophthalmology Science|March 5, 2026
Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network ReportJan Spindler, Dmitri Artemiev, Isabel B Pfister, et al.
Ophthalmology. Retina|March 26, 2025
One-Year Outcomes after Switching to Faricimab in Eyes with Pretreated Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportGabriela Grimaldi, Aude Ambresin, Isabel B Pfister, et al.
Health Science Reports|May 15, 2020
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger ToolAnne Gerber, André Da Silva Lopes, Natacha Szüts, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Ophthalmology Science|March 5, 2026
Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network ReportJan Spindler, Dmitri Artemiev, Isabel B Pfister, et al.
Ophthalmology. Retina|March 26, 2025
One-Year Outcomes after Switching to Faricimab in Eyes with Pretreated Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network ReportGabriela Grimaldi, Aude Ambresin, Isabel B Pfister, et al.
Health Science Reports|May 15, 2020
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger ToolAnne Gerber, André Da Silva Lopes, Natacha Szüts, et al.
Pageof 10